Description
Taltz (ixekizumab) is a prescription medication used to treat adults with moderate-to-severe plaque psoriasis, active psoriatic arthritis, and active ankylosing spondylitis. It is a type of drug called a monoclonal antibody that works by blocking interleukin-17A (IL-17A), a cytokine that plays a role in the pathogenesis of these diseases.
Uses:
Taltz is used to treat adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. It is also used to treat active psoriatic arthritis and active ankylosing spondylitis.
Storage Conditions:
Taltz should be refrigerated between 2°C to 8°C (36°F to 46°F) in its original package to protect it from light. Do not freeze or shake the medication.
Mechanism of Action:
Taltz is a monoclonal antibody that targets and neutralizes interleukin-17A (IL-17A), a cytokine that plays a key role in the pathogenesis of psoriasis, psoriatic arthritis, and ankylosing spondylitis. By blocking IL-17A, Taltz helps to reduce the inflammation associated with these conditions.
HOW TO USE:
Taltz is administered as a subcutaneous injection once every four weeks for plaque psoriasis, and once every two weeks for psoriatic arthritis and ankylosing spondylitis. The medication should be injected into the thigh, abdomen, or back of the upper arm, following the instructions provided by your doctor or nurse. Patients can self-administer the medication after proper training.
Precautions:
Before using Taltz, tell your doctor if you have any allergies or have ever had an allergic reaction to this medication or any of its ingredients. Inform your doctor if you have a history of infections or tuberculosis, or have been in close contact with someone with tuberculosis. Taltz may increase the risk of infections, including serious infections.
Drug Interactions:
Taltz may interact with certain medications, including immunomodulatory agents and live vaccines. Inform your doctor if you are taking any medications, including prescription and over-the-counter drugs, vitamins, and supplements.
Contraindications:
Do not use Taltz if you have ever had an allergic reaction to this medication or any of its ingredients.
Overdose:
There is no known antidote for Taltz. In case of an overdose, seek emergency medical attention.
Adverse Reactions:
The most common side effects of Taltz include injection site reactions, upper respiratory infections, nausea, and diarrhea. Taltz may also increase the risk of serious infections, such as tuberculosis and sepsis. If you experience any adverse reactions, inform your doctor or seek medical attention immediately.
In conclusion, Taltz is a monoclonal antibody medication used to treat adults with moderate-to-severe plaque psoriasis, active psoriatic arthritis, and active ankylosing spondylitis. It works by blocking interleukin-17A (IL-17A), a cytokine that plays a role in the pathogenesis of these diseases. Before using Taltz, inform your doctor of any allergies, history of infections, or medication use. It is administered as a subcutaneous injection once every two to four weeks, depending on the condition being treated. Common side effects include injection site reactions, upper respiratory infections, nausea, and diarrhea. Taltz may increase the risk of serious infections, so it is important to report any signs of infection or illness to your doctor immediately.
Reviews
There are no reviews yet.